Dashboard systems: Pharmacokinetic/pharmacodynamic mediated dose optimization for monoclonal antibodies
Author:
Affiliation:
1. Projections Research; Phoenixville; PA 19460 USA
2. Department of Pediatrics, IBD Center; Cedars-Sinai Medical Center; Los Angeles CA USA
Publisher
Wiley
Subject
Pharmacology (medical),Pharmacology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/jcph.370/fullpdf
Reference72 articles.
1. Inflammatory bowel disease: cause and immunobiology;Baumgart;Lancet,2007
2. European Crohnés and Colitis Organisation. European evidence based consensus on the diagnosis and management of Crohnés disease: current management;Travis;Gut,2006
3. Efficacy and safety of tumor necrosis factor antagonists in Crohn's disease: meta-analysis of placebo-controlled trials;Peyrin-Biroulet;Clin Gastroenterol Hepatol,2008
4. Trough serum infliximab: a predictive factor of clinical outcome for infliximab treatment in acute ulcerative colitis;Seow;Gut,2010
5. RISING study. Impact of trough serum level on radiographic and clinical response to infliximab plus methotrexate in patients with rheumatoid arthritis: results from the RISING study;Takeuchi;Mod Rheumatol,2009
Cited by 46 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. “Getting the Dose Right”—Revisiting the Topic With Focus on Biologic Agents;Clinical Pharmacology & Therapeutics;2024-04-28
2. Precision medicine in inflammatory bowel disease: Individualizing the use of biologics and small molecule therapies;World Journal of Gastroenterology;2023-03-14
3. Precision medicine in inflammatory bowel disease: Individualizing the use of biologics and small molecule therapies;World Journal of Gastroenterology;2023-03-14
4. Infliximab Therapy for Pediatric Crohn Disease and Ulcerative Colitis;Pediatric Inflammatory Bowel Disease;2023
5. Personalized Dosing of Infliximab in Patients With Inflammatory Bowel Disease Using a Bayesian Approach: A Next Step in Therapeutic Drug Monitoring;The Journal of Clinical Pharmacology;2022-12-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3